XML 90 R80.htm IDEA: XBRL DOCUMENT v3.23.2
Restatement of Prior Period (Details 1) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Mar. 31, 2023
Sep. 30, 2022
Mar. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Jun. 30, 2022
Jun. 30, 2021
Goodwill impairment charge       $ 51,500 $ 0 $ 4,280,100 $ 0
Total operating expenses $ 3,805,600   $ 3,288,900 6,455,100 6,291,500 17,280,800 9,684,200
Net loss $ (2,370,500)   $ (1,535,000) $ (4,079,400) $ (2,105,300) $ (13,668,100) $ (3,672,500)
Consolidated operations $ (0.34)   $ (0.23) $ (0.58) $ (0.33) $ (2.06) $ (1.15)
Income (Loss) from Operations $ (2,467,600)   $ (1,742,300) $ (4,137,000) $ (3,369,200) $ (11,544,100) $ (4,708,800)
Loss from continuing operations before income tax expense (benefit) (2,371,900)   (1,844,600) (4,073,100) (2,853,600) (11,281,700) (4,055,000)
Income tax expense (benefit), deferred 0   (222,100) 0 (737,300) 2,490,000 (945,000)
Income tax expense /(benefit) 0   (317,200) 0 737,300 (2,394,800) (1,152,500)
Loss from continuing operations (2,371,900)   (1,527,400) (4,073,100) (2,116,300) (13,672,500) (3,110,000)
Revenues 2,805,400   2,864,900 5,237,800 5,758,600 11,400,500 9,775,200
Cost of revenues 1,467,400   1,318,300 2,919,700 2,836,300 5,663,800 4,799,800
Gross profit 1,338,000   1,546,600 2,318,100 2,922,300 5,736,700 4,975,400
General and administrative 1,569,300   1,610,400 2,658,800 2,831,900 5,816,600 4,028,500
Selling 1,444,800   1,054,000 2,349,000 1,942,800 4,310,800 4,031,900
Research and development 791,500   624,500 1,395,800 1,516,800 2,873,300 1,623,800
Total other income, net       63,900 $ 515,600 262,400 653,800
Income tax (benefit), current $ 0   $ (95,100)        
Foreign currency translation gain (loss)       $ 88,600   (86,200) $ (9,200)
Effect of Restatement [Member]              
Goodwill impairment charge           4,280,100  
Total operating expenses           4,280,100  
Net loss   $ (417,200)       (8,023,700)  
Total comprehensive loss   $ (417,200)       $ (8,023,700)  
Continuing operations   $ (0.06)       $ (1.21)  
Discontinued operations   0.00       0.00  
Consolidated operations   $ (0.06)       $ (1.21)  
Income (Loss) from Operations           $ (4,280,100)  
Loss from continuing operations before income tax expense (benefit)           (4,280,100)  
Income tax expense (benefit), deferred   $ 417,200       3,743,600  
Income tax expense /(benefit)           3,743,600  
Loss from continuing operations   (417,200)       (8,023,700)  
As Filed [Member]              
Goodwill impairment charge           0  
Total operating expenses   3,043,300       13,000,700  
Net loss   (1,292,000)       (5,644,400)  
Total comprehensive loss   $ (1,406,200)       $ (5,740,800)  
Continuing operations   $ (0.18)       $ (0.85)  
Discontinued operations   0.00       0.00  
Consolidated operations   $ (0.18)       $ (0.85)  
Income (Loss) from Operations   $ (1,694,200)       $ (7,264,000)  
Loss from continuing operations before income tax expense (benefit)   (1,709,200)       (7,001,600)  
Income tax expense (benefit), deferred   (417,200)       (1,253,600)  
Income tax expense /(benefit)           (1,352,800)  
Loss from continuing operations   (1,292,000)       (5,648,800)  
Revenues   2,670,000       11,400,500  
Cost of revenues   1,320,900       5,663,800  
Gross profit   1,349,100       5,736,700  
General and administrative   1,607,500       5,816,600  
Selling   875,700       4,310,800  
Research and development   560,100       2,873,300  
Other income, net   (15,000)       185,100  
Interest income           77,300  
Total other income, net           262,400  
Income tax (benefit), current           (99,200)  
(Loss) Gain from discontinued operations, net of tax   0       4,400  
Unrealized holding gain (loss) on investment securities, net of tax   4,100       (10,200)  
Foreign currency translation gain (loss)   (118,300)       (86,200)  
Comprehensive gain (loss)   (114,200)       (96,400)  
As Restated [Member]              
Goodwill impairment charge           4,280,100  
Total operating expenses   3,043,300       17,280,800  
Net loss   (1,709,200)       (13,668,100)  
Total comprehensive loss   $ (1,823,400)       $ (13,764,500)  
Continuing operations   $ (0.24)       $ (2.06)  
Discontinued operations   0.00       0.00  
Consolidated operations   $ (0.24)       $ (2.06)  
Income (Loss) from Operations   $ (1,694,200)       $ (11,544,100)  
Loss from continuing operations before income tax expense (benefit)   (1,709,200)       (11,281,700)  
Income tax expense (benefit), deferred   0       (2,490,000)  
Income tax expense /(benefit)           2,390,800  
Loss from continuing operations   (1,709,200)       (13,672,500)  
Revenues   2,670,000       11,400,500  
Cost of revenues   1,320,900       5,663,800  
Gross profit   1,349,100       5,736,700  
General and administrative   1,607,500       5,816,600  
Selling   875,700       4,310,800  
Research and development   560,100       2,873,300  
Other income, net   (15,000)       185,100  
Interest income           77,300  
Total other income, net           262,400  
Income tax (benefit), current           (99,200)  
(Loss) Gain from discontinued operations, net of tax   0       4,400  
Unrealized holding gain (loss) on investment securities, net of tax   4,100       (10,200)  
Foreign currency translation gain (loss)   (118,300)       (86,200)  
Comprehensive gain (loss)   $ (114,200)       $ (96,400)